De Novo Melanomas May Be More Aggressive Than Nevus-associated Lesions

De novo melanomas, which arise from clinically normal skin with no associated nevus, may be more aggressive than nevus-associated melanomas, a study published in the Journal of the National Cancer Institute has shown.1

Approximately 20% to 30% of melanomas are associated with a nevus, while the majority of melanomas are de novo. Researchers sought to examine whether these forms of melanomas are associated with differences in patient survival and clinical and histopathologic features.

Continue Reading Below

For the study, investigators analyzed data from 2 prospective cohorts, which included a total of 2149 patients, conducted at NYU Langone Medical Center in New York City. Associations between melanoma classification and features were tested in the first cohort of 1024 patients and then replicated in the second cohort of 1125 patients.

Results showed that in the first cohort, de novo melanomas were associated with tumor thickness greater than 1.0 mm (odds ratio [OR] = 1.96; P <.001), ulceration (OR, 1.65; P =.02), nodular subtype (OR, 3.26; P =.001), greater than stage I (OR, 2.35; P <.001), and older age (OR = 1.64; P =.004).

Researchers also found that de novo melanomas were associated with shorter overall survival compared with nevus-associated melanomas (hazard ratio [HR], 1.63; 95% CI, 1.22-2.18; P <.001).

In the second cohort, de novo melanomas were again significantly associated with the aforementioned clinical and histopathologic features (all P <.001), as well as shorter overall survival (HR, 2.52; 95% CI, 1.78-3.56; P <.001).

Of note, the study demonstrated a statistically significantly poorer survival among male patients with de novo melanomas vs female patients with de novo melanomas; however, there was no difference in survival between patients of the opposite sex among those with nevus-associated lesions.

"This classification scheme may also provide a useful framework for investigations into sex differences in melanoma outcomes," the authors conclude.

Reference

1. Cymerman RM, Shao Y, Wang K, et al. De novo vs nevus-associated melanomas: differences in associations with prognostic indicators and survival. J Natl Cancer Inst. 2016 May 27. doi: 10.1093/jnci/djw121. [Epub ahead of print]

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs